Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Publication year range
1.
Rev. biol. trop ; 63(4)Oct.-Dec. 2015.
Article in Spanish | LILACS-Express | LILACS | ID: biblio-1507462

ABSTRACT

Rhizoprionodon lalandii es un pequeño tiburón ( 57 cm de LT), prohibir por completo el desembarque de hembras grávidas y decretar un periodo de veda de al menos cuatro meses al año, para preservar los beneficios económicos de la pesquería.


Rhizoprionodon lalandii is a small shark ( 57 cm de LT), ban the catches of pregnant females and the application of a banned season of at least four months per year, to preserve the economic benefits of this fishery.

2.
Mol Biochem Parasitol ; 125(1-2): 35-45, 2002.
Article in English | MEDLINE | ID: mdl-12467972

ABSTRACT

Trypanosoma cruzi and Leishmania parasites have a strict requirement for specific endogenous sterols (ergosterol and analogs) for survival and growth and cannot use the abundant supply of cholesterol present in their mammalian hosts. Squalene synthase (SQS, E.C. 2.5.1.21) catalyzes the first committed step in sterol biosynthesis and is currently under intense study as a possible target for cholesterol-lowering agents in humans, but it has not been investigated as a target for anti-parasitic chemotherapy. SQS is a membrane-bound enzyme in both T. cruzi epimastigotes and Leishmania mexicana promastigotes with a dual subcellular localization, being almost evenly distributed between glycosomes and mitochondrial/microsomal vesicles. Kinetic studies showed that the parasite enzymes display normal Michaelis-Menten kinetics and the values of the kinetic constants are comparable to those of the mammalian enzyme. We synthesized and purified 3-(biphenyl-4-yl)-3-hydroxyquinuclidine (BPQ-OH), a potent and specific inhibitor of mammalian SQS and found that it is also a powerful non-competitive inhibitor of T. cruzi and L. mexicana SQS, with K(i)'s in the range of 12-62 nM. BPQ-OH induced a dose-dependent reduction of proliferation the extracellular stages of these parasites with minimal growth inhibitory concentrations (MIC) of 10-30 microM. Growth inhibition and cell lysis induced by BPQ-OH in both parasites was associated with complete depletion of endogenous squalene and sterols, consistent with a blockade of de novo sterol synthesis at the level of SQS. BPQ-OH was able to eradicate intracellular T. cruzi amastigotes from Vero cells cultured at 37 degrees C, with a MIC of 30 microM with no deleterious effects on host cells. Taken together, these results support the notion that SQS inhibitors could be developed as selective anti-trypanosomatid agents.


Subject(s)
Antiprotozoal Agents/pharmacology , Farnesyl-Diphosphate Farnesyltransferase/antagonists & inhibitors , Leishmania mexicana/drug effects , Quinuclidines/pharmacology , Trypanosoma cruzi/drug effects , Animals , Antiprotozoal Agents/metabolism , Antiprotozoal Agents/therapeutic use , Chlorocebus aethiops , Drug Delivery Systems , Enzyme Inhibitors/pharmacology , Enzyme Inhibitors/therapeutic use , Farnesyl-Diphosphate Farnesyltransferase/chemistry , Farnesyl-Diphosphate Farnesyltransferase/isolation & purification , Kinetics , Leishmania mexicana/enzymology , Leishmania mexicana/growth & development , Life Cycle Stages , Models, Molecular , Protozoan Infections/drug therapy , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/enzymology , Trypanosoma cruzi/growth & development , Vero Cells
SELECTION OF CITATIONS
SEARCH DETAIL
...